Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Sepsis-induced immune dysfunction: can immune therapies reduce mortality?
Matthew J. Delano, Peter A. Ward
Matthew J. Delano, Peter A. Ward
Published January 4, 2016
Citation Information: J Clin Invest. 2016;126(1):23-31. https://doi.org/10.1172/JCI82224.
View: Text | PDF
Review Article has an altmetric score of 11

Sepsis-induced immune dysfunction: can immune therapies reduce mortality?

  • Text
  • PDF
Abstract

Sepsis is a systemic inflammatory response induced by an infection, leading to organ dysfunction and mortality. Historically, sepsis-induced organ dysfunction and lethality were attributed to the interplay between inflammatory and antiinflammatory responses. With advances in intensive care management and goal-directed interventions, early sepsis mortality has diminished, only to surge later after “recovery” from acute events, prompting a search for sepsis-induced alterations in immune function. Sepsis is well known to alter innate and adaptive immune responses for sustained periods after clinical “recovery,” with immunosuppression being a prominent example of such alterations. Recent studies have centered on immune-modulatory therapy. These efforts are focused on defining and reversing the persistent immune cell dysfunction that is associated with mortality long after the acute events of sepsis have resolved.

Authors

Matthew J. Delano, Peter A. Ward

×

Figure 2

Immune dysregulation in sepsis.

Options: View larger image (or click on image) Download as PowerPoint
Immune dysregulation in sepsis.
New insights into immune dysregulation h...
New insights into immune dysregulation have been gained using samples from deceased septic patients as well as from severely injured trauma patients. These studies demonstrate an enduring inflammatory state driven by dysfunctional innate and suppressed adaptive immunity that culminates in persistent organ injury and death of the patient. Although the initial inflammatory process, if unabated, contributes to organ failure and early mortality, this process is largely ameliorated by improvements in patient management protocols. However, considering that the vast majority of sepsis survivors are elderly with highly comorbid conditions, the short-term gains in survival have merely been pushed back by several months to a year. Although theories about the processes underlying this observation are numerous, the widespread consensus is that persistent derangements in innate and adaptive immune system cellular function are the main culprits driving long-term mortality.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Posted by 10 X users
Referenced in 2 patents
On 2 Facebook pages
Highlighted by 1 platforms
394 readers on Mendeley
See more details